Response to article by Johnna Perdrizet et al.,“Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants”
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2022-01-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Online Access: | http://dx.doi.org/10.1080/21645515.2021.1894898 |
| _version_ | 1797674477319880704 |
|---|---|
| author | Jorge A. Gómez Thatiana de Jesus Pereira Pinto Javier Nieto Guevara Tatiana Guimarães de Noronha |
| author_facet | Jorge A. Gómez Thatiana de Jesus Pereira Pinto Javier Nieto Guevara Tatiana Guimarães de Noronha |
| author_sort | Jorge A. Gómez |
| collection | DOAJ |
| first_indexed | 2024-03-11T22:00:34Z |
| format | Article |
| id | doaj.art-56f21fc0c07843fa98c6cc7fa725c099 |
| institution | Directory Open Access Journal |
| issn | 2164-5515 2164-554X |
| language | English |
| last_indexed | 2024-03-11T22:00:34Z |
| publishDate | 2022-01-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Human Vaccines & Immunotherapeutics |
| spelling | doaj.art-56f21fc0c07843fa98c6cc7fa725c0992023-09-25T11:17:06ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2022-01-0118110.1080/21645515.2021.18948981894898Response to article by Johnna Perdrizet et al.,“Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants”Jorge A. Gómez0Thatiana de Jesus Pereira Pinto1Javier Nieto Guevara2Tatiana Guimarães de Noronha3GlaxoSmithKlineGlaxoSmithKlineGlaxoSmithKlineInstitute of Technology for Immunobiologicals of Bio-Manguinhos, FIOCRUZhttp://dx.doi.org/10.1080/21645515.2021.1894898 |
| spellingShingle | Jorge A. Gómez Thatiana de Jesus Pereira Pinto Javier Nieto Guevara Tatiana Guimarães de Noronha Response to article by Johnna Perdrizet et al.,“Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants” Human Vaccines & Immunotherapeutics |
| title | Response to article by Johnna Perdrizet et al.,“Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants” |
| title_full | Response to article by Johnna Perdrizet et al.,“Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants” |
| title_fullStr | Response to article by Johnna Perdrizet et al.,“Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants” |
| title_full_unstemmed | Response to article by Johnna Perdrizet et al.,“Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants” |
| title_short | Response to article by Johnna Perdrizet et al.,“Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants” |
| title_sort | response to article by johnna perdrizet et al cost effectiveness analysis of replacing the 10 valent pneumococcal conjugate vaccine pcv10 with the 13 valent pneumococcal conjugate vaccine pcv13 in brazil infants |
| url | http://dx.doi.org/10.1080/21645515.2021.1894898 |
| work_keys_str_mv | AT jorgeagomez responsetoarticlebyjohnnaperdrizetetalcosteffectivenessanalysisofreplacingthe10valentpneumococcalconjugatevaccinepcv10withthe13valentpneumococcalconjugatevaccinepcv13inbrazilinfants AT thatianadejesuspereirapinto responsetoarticlebyjohnnaperdrizetetalcosteffectivenessanalysisofreplacingthe10valentpneumococcalconjugatevaccinepcv10withthe13valentpneumococcalconjugatevaccinepcv13inbrazilinfants AT javiernietoguevara responsetoarticlebyjohnnaperdrizetetalcosteffectivenessanalysisofreplacingthe10valentpneumococcalconjugatevaccinepcv10withthe13valentpneumococcalconjugatevaccinepcv13inbrazilinfants AT tatianaguimaraesdenoronha responsetoarticlebyjohnnaperdrizetetalcosteffectivenessanalysisofreplacingthe10valentpneumococcalconjugatevaccinepcv10withthe13valentpneumococcalconjugatevaccinepcv13inbrazilinfants |